Showing results (561-570 of 698) with videos related to

Sort By:
Pageof 70
Leukemia|January 21, 2006
Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemiaG Heil, D Hoelzer, M A Sanz, et al.
Transplantation|June 9, 2001
Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantationW Rabitsch, E Deviatko, F Keil, et al.
Annals of Surgery|July 20, 2016
Regionalization of Emergent Vascular Surgery for Patients With Ruptured AAA Improves OutcomesCourtney J Warner, Sean P Roddy, Benjamin B Chang, et al.
Thrombosis and Haemostasis|March 1, 1995
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in manM Wolzt, A Weltermann, M Nieszpaur-Los, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin)S Eichinger, M Wolzt, B Schneider, et al.
Kidney International|December 1, 1990
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRFM Heistinger, F Stockenhuber, B Schneider, et al.
American Journal of Hematology|January 1, 1994
Autoimmune-thrombocytopenia and SLE in a patient with 5q-anomaly and deletion of the c-fms oncogeneU Jaeger, S Panzer, C Bartram, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1992
Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivoB Wagner, H G Eichler, B Schneider, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Effect of ritanserin, a 5-hydroxytryptamine2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivoB Wagner, B Schneider, B Blöchl-Daum, et al.
Thrombosis and Haemostasis|October 1, 1995
Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb)P Knöbl, K Derfler, L Korninger, et al.
Pageof 70